Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer
Journal of the Academy of Consultation-Liaison Psychiatry January 21, 2021 Brian S. Barnett, George R. Greer 13 citations
Psychedelic compounds have a long and complex history with psychiatry, having been widely used in clinical settings a half century ago before being outlawed in the United States in 1970 due to concerns about abuse potential and their association with the counterculture movement. In recent years, a resurgence of research has revealed early evidence supporting psychedelic-assisted therapy for treating alcohol use disorder, nicotine use disorder, posttraumatic stress disorder, and depression. The literature indicates that psychedelic-assisted therapies may have treatment potential for mental illness and addiction, though adverse events from nonmedical use are rare. Current data suggest that, if administered thoughtfully by trained professionals in medical settings, psychedelic-assisted therapy could reduce suffering from mental illness and addiction.